Gray Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,349
Closed -$267K 138
2024
Q3
$267K Buy
2,349
+2
+0.1% +$238 0.11% 107
2024
Q2
$291K Buy
2,347
+1
+0% +$129 0.13% 99
2024
Q1
$310K Buy
2,346
+200
+9% +$24.7K 0.14% 93
2023
Q4
$234K Buy
2,146
+141
+7% +$14.6K 0.11% 111
2023
Q3
$206K Buy
2,005
+2
+0.1% +$216 0.11% 126
2023
Q2
$231K Buy
2,003
+14
+0.7% +$1.59K 0.12% 109
2023
Q1
$212K Buy
1,989
+96
+5% +$10.4K 0.12% 113
2022
Q4
$210K Buy
+1,893
New +$193K 0.12% 110

Other funds holding MRK

Gray Wealth Management's MRK Position: Q4 2024 in Review

Gray Wealth Management sold out of Merck (MRK) in Q4 2024, closing a stake of 2,349 shares — an estimated $267K sold.

Gray Wealth Management first reported a position in MRK in Q4 2022 and held it in 8 quarters. The position peaked at $310K in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Gray Wealth Management reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Gray Wealth Management sold 2,349 Merck shares in Q4 2024, an estimated $267K.
  • Gray Wealth Management first reported a position in Merck in Q4 2022 and held it in 8 quarters.
  • Gray Wealth Management's Merck position peaked at $310K in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Gray Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.